We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.93B
AUM Growth
+$244M
Cap. Flow
+$17M
Cap. Flow %
0.43%
Top 10 Hldgs %
14.31%
Holding
1,432
New
108
Increased
538
Reduced
575
Closed
84

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$7.62M
2
BABA icon
Alibaba
BABA
+$7.25M
3
TDOC icon
Teladoc Health
TDOC
+$4.82M
4
TSN icon
Tyson Foods
TSN
+$4.64M
5
QCOM icon
Qualcomm
QCOM
+$3.85M

Sector Composition

Rank Sector Weight
1 Technology 13.34%
2 Healthcare 12.65%
3 Financials 11.21%
4 Industrials 9.34%
5 Consumer Discretionary 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DD icon
26
DuPont de Nemours
DD
$18.7B
$26.3M 0.67%
161,729
+4,016
+3% +$691K
DIS icon
27
Walt Disney
DIS
$167B
$25.9M 0.66%
221,846
+4,594
+2% +$511K
GOOGL icon
28
Alphabet (Google) Class A
GOOGL
$4.08T
$25.9M 0.66%
429,000
-2,040
-0.5% -$123K
C icon
29
Citigroup
C
$222B
$25.5M 0.65%
354,981
+4,323
+1% +$306K
MTUM icon
30
iShares MSCI USA Momentum Factor ETF
MTUM
$24.9B
$25.3M 0.64%
212,788
+2,118
+1% +$244K
IBM icon
31
IBM
IBM
$209B
$24.6M 0.63%
170,512
-334
-0.2% -$46.7K
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$24.5M 0.62%
84,122
+310
+0.4% +$88.3K
EPD icon
33
Enterprise Products Partners
EPD
$82.5B
$24.1M 0.61%
839,390
-2,414
-0.3% -$69.8K
LUV icon
34
Southwest Airlines
LUV
$22.3B
$23.3M 0.59%
373,557
-10,914
-3% -$638K
TMO icon
35
Thermo Fisher Scientific
TMO
$214B
$22.5M 0.57%
92,226
-1,955
-2% -$450K
BMY icon
36
Bristol-Myers Squibb
BMY
$132B
$21.2M 0.54%
341,949
-569
-0.2% -$33.8K
BABA icon
37
Alibaba
BABA
$279B
$21M 0.53%
127,289
+40,984
+47% +$7.25M
MRK icon
38
Merck
MRK
$321B
$20.8M 0.53%
307,778
+9,369
+3% +$597K
HON icon
39
Honeywell
HON
$76.7B
$19.9M 0.51%
132,526
-4,408
-3% -$625K
NVGS icon
40
Navigator Holdings
NVGS
$1.37B
$19.8M 0.51%
1,639,793
-16,900
-1% -$207K
CVX icon
41
Chevron
CVX
$383B
$19.5M 0.5%
159,485
+1,462
+0.9% +$177K
NFLX icon
42
Netflix
NFLX
$305B
$19.4M 0.49%
517,760
+30,070
+6% +$1.09M
INTC icon
43
Intel
INTC
$460B
$19.2M 0.49%
406,424
-15,149
-4% -$737K
ABBV icon
44
AbbVie
ABBV
$455B
$18.3M 0.47%
193,862
-9,795
-5% -$929K
PEP icon
45
PepsiCo
PEP
$191B
$17.9M 0.46%
160,516
-1,513
-0.9% -$171K
EHC icon
46
Encompass Health
EHC
$11B
$17.8M 0.45%
286,790
-6,285
-2% -$382K
UNH icon
47
UnitedHealth
UNH
$383B
$17.8M 0.45%
66,841
+7,317
+12% +$1.9M
MDY icon
48
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$17.5M 0.45%
47,738
+497
+1% +$182K
NVDA icon
49
NVIDIA
NVDA
$4.72T
$17M 0.43%
2,422,720
+110,120
+5% +$716K
RTN
50
DELISTED
Raytheon Company
RTN
$16.3M 0.41%
78,644
-5,942
-7% -$1.18M

Similar funds

Oppenheimer & Co's Q3 2018 Portfolio in Review

As of Q3 2018, Oppenheimer & Co held 1,432 positions worth $3.93B, up 6.6% from $3.68B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2018 filing shows 108 new, 538 increased, 575 reduced and 84 closed positions. Its largest new stake was Invesco DB Commodity Index Tracking Fund: 113,354 shares worth $2.04M. The largest sale was A V Homes, Inc., an estimated $12.7M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q3 2018 buy was Invesco DB Commodity Index Tracking Fund: 113,354 shares worth $2.04M.
  • Oppenheimer & Co added most to Meta Platforms (Facebook) in Q3 2018, an estimated $7.62M increase.
  • Oppenheimer & Co's biggest Q3 2018 reduction was Wabtec, cutting an estimated $4.88M.
  • Oppenheimer & Co fully exited A V Homes, Inc. in Q3 2018, selling an estimated $12.7M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.93B portfolio in Q3 2018.
  • Oppenheimer & Co opened 108 new positions and closed 84 in Q3 2018.
  • Oppenheimer & Co's portfolio value rose 6.6% quarter-over-quarter to $3.93B.

Based on Oppenheimer & Co's 13F filing for Q3 2018, filed 26 Oct 2018.